Cholesterol-Lowering Claim Disease Status Protested By McNeil
This article was originally published in The Tan Sheet
Executive Summary
McNeil Consumer Healthcare opposes FDA's classification of certain cholesterol-lowering claims as disease claims in the final rule on dietary supplement structure/function claims. In a Feb. 7 citizen petition, McNeil asks the agency to reconsider its decision.
You may also be interested in...
Mars CocoaVia Chocolate Bars Receive No Kudos In FDA Warning Letter
CocoaVia chocolate bars are adulterated "in that they contain a food additive, namely folic acid, which is unsafe within the meaning of section 409" of the FD&C Act, CFSAN Office of Compliance Director Joseph Baca tells Mars in a recent warning letter
Mars CocoaVia Chocolate Bars Receive No Kudos In FDA Warning Letter
CocoaVia chocolate bars are adulterated "in that they contain a food additive, namely folic acid, which is unsafe within the meaning of section 409" of the FD&C Act, CFSAN Office of Compliance Director Joseph Baca tells Mars in a recent warning letter
Mars CocoaVia Chocolate Bars Receive No Kudos In FDA Warning Letter
CocoaVia chocolate bars are adulterated "in that they contain a food additive, namely folic acid, which is unsafe within the meaning of section 409" of the FD&C Act, CFSAN Office of Compliance Director Joseph Baca tells Mars in a recent warning letter